NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

Adult Therapeutics Handbook: Content Update Sept 2017

Posted: September 07, 2017.
Category - Medicines Update Acute

Adult Therapeutics Handbook: Content Update Sept 2017   The Therapeutics Handbook content has now been updated and includes the following main change:

Read More...

GMAWS - Updated Alcohol Withdrawal Recommendations

Posted: September 06, 2017.
Category - Medicines Update

UPDATED ALCOHOL WITHDRAWAL RECOMMENDATIONS Summary of Key Changes New Pabrinex® prescription recommendations for patients ‘at risk’ of Wernicke’s Encephalopa...

Read More...

Formulary Update (August 2017)

Posted: September 04, 2017.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Hepatitis B Vaccine Supply Update

Posted: August 30, 2017.
Category - Medicines Update

Highlights the current shortage of adult hepatitis B vaccine.

Read More...

MHRA Updates July & August 2017

Posted: August 28, 2017.
Category - Medicines Update

Drug Safety Update (August 2017) includes: Ibrutinib (Imbruvica ...

Read More...

Oral NSAIDs – What’s new?

Posted: August 25, 2017.
Category - Medicines Update

The GGC Oral NSAID guideline has recently been updated. Ibuprofen and naproxen remain the NSAIDs of choice. The prescribing notes have been updated and include additional information on acute kidney injury and hepatic impairment.

Read More...

MUE 06: Oral NSAIDs - An Update

Posted: August 25, 2017.
Category - Medicines Update Extra

 

 Oral NSAIDs - An Update

** This bulletin supersedes PostScript Extra No. 24 **

  • There is considerable variation in individual response and tolerance to NSAIDs, but little difference in anti-inflammatory activity.
  • All NSAIDs should be avoided if possible in patients with a history of vascular disease, a high risk of cardiovascular disease (CVD), or gastrointestinal (GI) risk factors.
  • Treatment choice depends on individual response, risk factors and adverse effects, particularly GI and cardiovascular (CV) complications.
  • The lowest effective dose to control the patient’s symptoms, for the shortest duration possible, should be used. The use of ‘as required’ NSAIDs should be considered where appropriate.
  • The preferred non-selective NSAIDs are ibuprofen or naproxen. A proton pump inhibitor (PPI) may be required depending on GI risk.


Read More...

Zomorph® - Preferred Brand Oral Morphine M/R in Adults

Posted: August 25, 2017.
Category - Medicines Update

MST® is currently the most frequently prescribed brand of morphine sulphate modified release (M/R) across NHSGGC. From 01/09/2017 the preferred choice of solid morphine sulphate M/R across primary and secondary care will change to Zomorph® capsules. 

Read More...

VTE – Diagnosis, treatment and prevention

Posted: August 25, 2017.
Category - Medicines Update

A site dedicated to the prevention,diagnosis and management of venous thromboembolism (VTE) has recently been introduced onto StaffNet.

Read More...

Patients should finish the course of antibiotics

Posted: August 25, 2017.
Category - Medicines Update

Concerns have been raised regarding the opinion piece published in the BMJ regarding antibiotic courses. See response from Dr Andrew Seaton, Chairman of the Scottish Antimicrobial Prescribing Group (SAPG).

Read More...